Dr. Laughton E. Miles, M.D., PH.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 10300 W Loyola Dr, Los Altos Hills, CA 94024 Phone: 650-917-9982 Fax: 650-949-1420 |
News Archive
Foregoing food for a day each month stood out among other religious practices in members of the Church of Jesus Christ of Latter-Day Saints (LDS or Mormons), who have lower rates of heart disease than other Americans, researchers reported at the American Heart Association's Scientific Sessions 2007.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, announced the National Cancer Institute (NCI) will sponsor a multi-center phase 2 study of Syndax's lead product entinostat, a novel inhibitor of histone deacetylases (HDAC), and anastrozole, an aromatase inhibitor, in postmenopausal women with operable triple negative breast cancer to evaluate biomarkers and surrogates for response.
On September 8th, the company XenOPAT SL, a spin-off of the Institute of Biomedical Research and the Catalan Institute of Oncology was established with the aim of bringing the company the latest scientific developments to the service combating cancer with two main branches: the development of new drugs and advance the implementation of personalized cancer treatments.
New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.
Rates of depression and stress have increased among the general population since the COVID-19 pandemic began. However, we know little about the current state of mental health of older adults (65+), who are at a higher risk for illness and death due to infection, and account for more than 95% of COVID-19 deaths in Ontario.
› Verified 9 days ago